“car-t-immunotherapy” Archives

in
Entry Author Date Location
MorphoSys, Incyte Get Early FDA Nod for Antibody Alternative to CAR-T 08/03/20 Europe
AlloVir’s IPO Raises $276M to Test Cell Therapies in Transplant Patients 07/30/20 Boston
Orca Bio Surfaces With $192M and Recipes for “Custom” Cell Therapies 06/17/20 San Francisco
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact 05/27/20 San Francisco
Encouraging Signals for New Cancer Cell Therapy Strategies 05/06/20 National
Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal 01/16/20 Boston
TScan Lands $48M for Better, Safer T-Cell Receptor Cancer Therapies 07/24/19 Boston
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Precision Bio Preps IPO to Test “Off-the-Shelf” Cancer Cell Therapy 03/04/19 Raleigh Durham
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
TCR²’s IPO Raises $75M to Bring Cancer Cell Therapy to Solid Tumors 02/14/19 Boston
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango 10/31/18 San Francisco
CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy 09/17/18 San Diego
Allogene Files for IPO to Fund Cancer Cell Therapy Clinical Trials 09/14/18 San Francisco
Xconomy’s San Francisco Event to Showcase Biotech’s Next Generation 09/13/18 San Francisco
RootPath Raises $7M to Bring Cancer Cell Therapy to Solid Tumors 08/30/18 Boston
Bluebird Bio Turns to Gritstone’s A.I. to Find TCR Cancer Targets 08/23/18 Boston
Bluebird, Regeneron Team Up To Make Cell Therapies For Cancer 08/06/18 New York
Unum, Homology Plan IPOs, as Unum Reveals Two Patient Deaths 03/05/18 Boston
Tmunity Reels in $100M for “Next Generation” Cancer Immunotherapy 01/23/18 National
Gilead Bets on Cell Therapy Again with $567M Cell Design Labs Deal 12/07/17 San Francisco
With $25M, Torque Aims for a More Targeted Cell Therapy for Cancer 11/14/17 Boston
Bio Roundup: Kite’s CAR-T Approved, Obamacare Fix & Lilly mRNA Deal 10/20/17 National
Bio Roundup: PDUFA Progress, BCRA Redux, CAR-T Thumbs Up, & More 07/14/17 National
Kite CAR-T Death: An Unwelcome Mystery as FDA Mulls Approval 05/08/17 National
Bio Roundup: Trump Budget, FDA Chief, CAR-T Qs, CRISPR Cash, & More 03/17/17 National
Bio Roundup: Healthcare Is Hard, “Slow” FDA, Drugging RNA & More 03/03/17 National
West Coast Biotech Roundup: Juno, Tekmira, True North, aTyr & More 04/10/15 Seattle
Juno, Novartis End CAR-T Patent Fight, With Juno A Little Richer 04/06/15 Seattle
Page 1 of 2 next page »